Publications:  Prof Adina Michael-Titus

Nessel I, Michael-Titus AT(2020). Lipid profiling of brain tissue and blood after traumatic brain injury: A review of human and experimental studies. Semin Cell Dev Biol

Zirpoli H, Chang CL, Carpentier YA, Michael-Titus AT, Ten VS, Deckelbaum RJ(2020). Novel Approaches for Omega-3 Fatty Acid Therapeutics: Chronic Versus Acute Administration to Protect Heart, Brain, and Spinal Cord. Annu Rev Nutr vol. 40, 161-187.

Vrettos EI, Valverde IE, Mascarin A, Pallier PN, Cerofolini L, Fragai M, Parigi G, Hirmiz B et al.(2020). Cover Feature: Single Peptide Backbone Surrogate Mutations to Regulate Angiotensin GPCR Subtype Selectivity (Chem. Eur. J. 47/2020). Chemistry - A European Journal vol. 26, (47) 10646-10646.

Vrettos EI, Valverde IE, Mascarin A, Pallier PN, Cerofolini L, Fragai M, Parigi G, Hirmiz B et al.(2020). Single peptide backbone surrogate mutations to regulate angiotensin GPCR subtype selectivity. Chemistry: A European Journal Article chem.202000924,

Yip PK, Schmitzberger M, Al-Hasan M, George J, Tripoliti E, Michael-Titus AT, Clayton D, Priestley JV(2020). Serotonin expression in the song circuitry of adult male zebra finches. Neuroscience

Lilley E, Andrews MR, Bradbury EJ, Elliott H, Hawkins P, Ichiyama RM, Keeley J, Michael-Titus AT et al.(2020). Refining rodent models of spinal cord injury. Experimental Neurology vol. 328,

Thau-Zuchman O, Ingram R, Harvey GG, Cooke T, Palmas F, Pallier PN, Brook J, Priestley JV et al.(2020). A single injection of docosahexaenoic acid induces a pro-resolving lipid mediator profile in the injured tissue and a long-lasting reduction in neurological deficit after traumatic brain injury in mice. Journal of Neurotrauma vol. 37, (1) 66-79.

Yip PK, Bowes AL, Hall JCE, Burguillos MA, Richard Ip TH, Baskerville T, Liu ZH, Mohamed MAEK et al.(2019). Docosahexaenoic acid reduces microglia phagocytic activity via miR-124 and induces neuroprotection in rodent models of spinal cord contusion injury. Human Molecular Genetics vol. 28, (14) 2427-2448.

Zuchman OT, Svendsen L, Groenendijk M, de Wilde MC, Tremoleda JL, Michael-Titus AT (2019). A NEW KETOGENIC FORMULATION IMPROVES FUNCTIONAL OUTCOME AND REDUCES TISSUE DAMAGE FOLLOWING TRAUMATIC BRAIN INJURY. JOURNAL OF NEUROTRAUMA. vol. 36, A131-A132.

Yip PK, Chapman GE, Sillito RR, Ip THR, Akhigbe G, Becker SC, Price AW, Michael-Titus AT et al.(2019). Studies on long term behavioural changes in group-housed rat models of brain and spinal cord injury using an automated home cage recording system. Journal of Neuroscience Methods vol. 321, 49-63.

Thau-Zuchman O, Gomes RN, Dyall SC, Davies M, Priestley JV, Groenendijk M, De Wilde MC, Tremoleda JL et al.(2019). Brain Phospholipid Precursors Administered Post-Injury Reduce Tissue Damage and Improve Neurological Outcome in Experimental Traumatic Brain Injury. Journal of Neurotrauma vol. 36, (1) 25-42.

Adolph M, Calder PC, Deutz NE, Carmona TG, Klek S, Lev S, Mayer K, Michael-Titus AT et al.(2018). Commentary on "Fish Oil-Containing Lipid Emulsions in Adult Parenteral Nutrition: A Review of the Evidence" (https://doi.org/10.1177/0148607117721907). JPEN J Parenter Enteral Nutr

Shah DK, Ponnusamy V, Evanson J, Kapellou O, Ekitzidou G, Gupta N, Clarke P, Michael-Titus AT et al.(2018). Raised plasma neurofilament light protein levels are associated with abnormal MRI outcomes in newborns undergoing therapeutic hypothermia. Frontiers in Neurology vol. 9, (MAR)

Calder PC, Adolph M, Deutz NE, Grau T, Innes JK, Klek S, Lev S, Mayer K et al.(2018). Lipids in the intensive care unit: Recommendations from the ESPEN Expert Group. Clin Nutr vol. 37, (1) 1-18.

Alvarez K, Lopez-Tremoleda J, Donnan R, Michael-Titus AT, Tomlins PH (2018). Heart rate sensitive optical coherence angiography. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. vol. 10493,

Lopez-Tremoleda J, Alvarez K, ADEN A, DONNAN RS, MICHAEL-TITUS AT, TOMLINS PH(2017). Heart-rate sensitive optical coherence angiography for measuring vascular changes due to posttraumatic brain injury in mice. Journal of Biomedical Optics vol. 22, (12) 121710-121710.

Venero JL, Yip PK, Carrillo-Jimenez A, King P, Vilalta A, Nomura K, Chau CC, Tr AMSEZ-HLAJSJL et al. (2017). Galectin-3 acts as an early alarmin orchestrating brain immune response and promoting neurodegeneration after traumatic brain injury. GLIA. Conference: XIII European Glial Meeting vol. 65, E504-E504.

Lee WLA, Michael-Titus AT, Shah DK(2017). Hypoxic-Ischaemic Encephalopathy and the Blood-Brain Barrier in Neonates. Developmental Neuroscience vol. 39, (1-4) 49-58.

Yip PK, Carrillo-Jimenez A, King P, Vilalta A, Nomura K, Chau CC, Egerton AMS, Liu Z-H et al.(2017). Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration. Scientific Reports vol. 7, Article 41689, 41689-41689.

Liu Z-H, Yip PK, Priestley JV, Michael-Titus AT(2017). A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat. J Neurotrauma vol. 34, (9) 1766-1777.

Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Vadivelu KC, Yip PK, Sosabowski J et al.(2016). In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [18F]GE-180 and effect of docosahexaenoic acid. European Journal of Nuclear Medicine and Molecular Imaging

Ponnusamy V, Kapellou O, Yip E, Evanson J, Wong LF, Michael-Titus A, Yip PK, Shah DK(2016). A study of microRNAs from dried blood spots in newborns after perinatal asphyxia: A simple and feasible biosampling method. Pediatric Research vol. 79, (5) 799-805.

Thau-Zuchman O, Pallier PN, Davies M, Groenendijk M, de Wilde MC, Tremoleda JL, Michael-Titus AT(2016). A specific multi-nutrient intervention, designed to enhance synapse formation and function, improves functional outcome following traumatic brain injury. BRAIN INJURY vol. 30, (5-6) 679-679.

Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Trigg W, Sosabowski J, Mather SJ et al. (2015). IN VIVO IMAGING OF NEUROINFLAMMATION IN NEUROTRAUMA PRECLINICAL MODELS: POTENTIAL FOR CLINICAL TRANSLATION. SHOCK. vol. 44, 24-25.

Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Trigg W, Sosabowski J, Mather SJ et al.(2015). T-14: IN VIVO IMAGING OF NEUROINFLAMMATION IN NEUROTRAUMA PRECLINICAL MODELS: POTENTIAL FOR CLINICAL TRANSLATION. Shock vol. 44 Suppl 2, 24-25.

Pallier PN, Poddighe L, Zbarsky V, Kostusiak M, Choudhury R, Hart T, Burguillos MA, Musbahi O et al.(2015). A nutrient combination designed to enhance synapse formation and function improves outcome in experimental spinal cord injury. Neurobiology of Disease vol. 82, 504-515.

Liu ZH, Yip PK, Adams L, Davies M, Lee JW, Michael GJ, Priestley JV, Michael-Titus AT(2015). A single bolus of docosahexaenoic acid promotes neuroplastic changes in the innervation of spinal cord interneurons and motor neurons and improves functional recovery after spinal cord injury. Journal of Neuroscience vol. 35, (37) 12733-12752.

Ward RE, Huang W, Kostusiak M, Pallier PN, Michael-Titus AT, Priestley JV(2014). A characterization of white matter pathology following spinal cord compression injury in the rat. Neuroscience vol. 260, 227-239.

Paterniti I, Impellizzeri D, Di Paola R, Esposito E, Gladman S, Yip P, Priestley JV, Michael-Titus AT et al.(2014). Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies. J Neuroinflammation vol. 11,

Michael-Titus AT, Priestley JV(2014). Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity?. Trends Neurosci vol. 37, (1) 30-38.

Nikolakopoulou Z, Nteliopoulos G, Michael-Titus AT, Parkinson EK(2013). Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2. Carcinogenesis vol. 34, (12) 2716-2725.

Nikolakopoulou Z, Shaikh MH, Dehlawi H, Michael-Titus AT, Parkinson EK(2013). The induction of apoptosis in pre-malignant keratinocytes by omega-3 polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) is inhibited by albumin. Toxicol Lett vol. 218, (2) 150-158.

Lim S-N, Gladman SJ, Dyall SC, Patel U, Virani N, Kang JX, Priestley JV, Michael-Titus AT(2013). Transgenic mice with high endogenous omega-3 fatty acids are protected from spinal cord injury. Neurobiol Dis vol. 51, 104-112.

Perera AP, Kotarba K, Kenny F, Connelly J, Michael-Titus A, Wheeler A (2013). Characterising the effect of substrate stiffness on macrophage behaviour. MOLECULAR BIOLOGY OF THE CELL. vol. 24,

Lim S-N, Huang W, Hall JCE, Michael-Titus AT, Priestley JV(2013). Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. Exp Neurol vol. 239, 13-27.

Yip PK, Pizzasegola C, Gladman S, Biggio ML, Marino M, Jayasinghe M, Ullah F, Dyall SC et al.(2013). The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS One vol. 8, (4)

Hall JCE, Priestley JV, Perry VH, Michael-Titus AT(2012). Docosahexaenoic acid, but not eicosapentaenoic acid, reduces the early inflammatory response following compression spinal cord injury in the rat. J Neurochem vol. 121, (5) 738-750.

Gladman SJ, Huang W, Lim S-N, Dyall SC, Boddy S, Kang JX, Knight MM, Priestley JV et al.(2012). Improved outcome after peripheral nerve injury in mice with increased levels of endogenous ω-3 polyunsaturated fatty acids. J Neurosci vol. 32, (2) 563-571.

Priestley JV, Michael-Titus AT, Tetzlaff W(2012). Limiting spinal cord injury by pharmacological intervention. Handb Clin Neurol vol. 109, 463-484.

Gladman S, Lim SN, Dyall S, Knight MM, Priestley JV, Michael-Titus AT(2011). Omega-3 fatty acids and acute neurological trauma: A perspective on clinical translation. OCL - Oleagineux Corps Gras Lipides vol. 18, (6) 317-323.

Zbarsky-Barquero¿ V, Sijben J, De Wilde M, Priestley JV, Michael-Titus AT(2011). A multi-nutrient composition with neuroprotective properties in spinal cord injury. European Journal of Pharmacology vol. 668, e10-e11.

Wann AKT, Mistry J, Blain EJ, Michael-Titus A, Knight MM (2011). Eicosapenaenoic acid (EPA) and docasahexaenoic acid (DHA) reduce IL-1 beta mediated cartilage degradation. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. vol. 92, A11-A12.

Gladman SJ, Ward RE, Michael-Titus AT, Knight MM, Priestley JV(2010). The effect of mechanical strain or hypoxia on cell death in subpopulations of rat dorsal root ganglion neurons in vitro. Neuroscience vol. 171, (2) 577-587.

Jokic N, Yip PK, Michael-Titus A, Priestley JV, Malaspina A(2010). The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression. BMC Genomics vol. 11, 633-633.

Ward RE, Huang W, Curran OE, Priestley JV, Michael-Titus AT(2010). Docosahexaenoic acid prevents white matter damage after spinal cord injury. J Neurotrauma vol. 27, (10) 1769-1780.

Lim S-N, Huang W, Hall JCE, Ward RE, Priestley JV, Michael-Titus AT(2010). The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot Essent Fatty Acids vol. 83, (4-6) 193-201.

Malaspina A, Ngoh SFA, Ward RE, Hall JCE, Tai FWD, Yip PK, Jones C, Jokic N et al.(2010). Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis. Neuroscience vol. 169, (2) 812-827.

Dyall SC, Michael GJ, Michael-Titus AT(2010). Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J Neurosci Res vol. 88, (10) 2091-2102.

Robson LG, Dyall S, Sidloff D, Michael-Titus AT(2010). Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol Aging vol. 31, (4) 678-687.

Kiasalari Z, Salehi I, Zhong Y, McMahon SB, Michael-Titus AT, Michael GJ(2010). Identification of Perineal Sensory Neurons Activated by Innocuous Heat. J COMP NEUROL vol. 518, (2) 137-162.

Michael-Titus A, Revest P, Shortland P(2010). 1 ORGANIZATION OF THE NERVOUS SYSTEM. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 10 MOTOR SYSTEMS II THE BASAL GANGLIA. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 11 STROKE AND HEAD INJURY. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 12 INFECTION IN THE CENTRAL NERVOUS SYSTEM. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 13 EPILEPSY. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 14 DEMENTIA. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 15 SCHIZOPHRENIA. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 16 DEPRESSION AND ANXIETY. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 17 ADDICTION. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 2 ELEMENTS OF CELLULAR AND MOLECULAR NEUROSCIENCE. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 3 CLINICAL EXAMINATION. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 4 THE SPINAL CORD. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 5 PAIN AND ANALGESIA. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 6 CRANIAL NERVES AND THE BRAINSTEM. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 7 THE VISUAL SYSTEM. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 8 HEARING AND BALANCE THE AUDITORY AND VESTIBULAR SYSTEMS. The Nervous System,

Michael-Titus A, Revest P, Shortland P(2010). 9 MOTOR SYSTEMS I DESCENDING PATHWAYS AND CEREBELLUM. The Nervous System,

Wann AK, Mistry J, Michael-Titus A, Knight MM (2010). Eicosapenaenoic acid (EPA) and docasahexaenoic acid (DHA) reduce IL-1β mediated cartilage degradation. European Cells and Materials. vol. 20,

Wann AKT, Mistry J, Blain EJ, Michael-Titus AT, Knight MM(2010). Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation. Arthritis Res Ther vol. 12, (6)

Nikolakopoulou Z, Michael¿Titus AT, Parkinson EK (2009). Abstract B152: The selective effect of omega‐3 polyunsaturated fatty acids on normal and neoplastic oral keratinocyte apoptosis. b152-b152.

Huang WL, Bhavsar A, Ward RE, Hall JCE, Priestley JV, Michael-Titus AT(2009). Arachidonyl Trifluoromethyl Ketone Is Neuroprotective after Spinal Cord Injury. J NEUROTRAUM vol. 26, (8) 1429-1434.

Huang W, Bhavsar A, Ward RE, Hall JCE, Priestley JV, Michael-Titus AT(2009). Arachidonyl trifluoromethyl ketone is neuroprotective after spinal cord injury. J Neurotrauma vol. 26, (8) 1429-1434.

Hall JCE, Priestley JV, Perry VH, Michael-Titus A (2009). WINTR VISA AWARD WINNER DOES ACUTE TREATMENT WITH DOCOSAHEXAENOIC OR EICOSAPENTAENOIC ACID AFFECT INFLAMMATORY MARKERS FOLLOWING COMPRESSION SPINAL CORD INJURY?. JOURNAL OF NEUROTRAUMA. vol. 26, A45-A45.

Michael-Titus AT(2009). Omega-3 fatty acids: their neuroprotective and regenerative potential in traumatic neurological injury. CLIN LIPIDOL vol. 4, (3) 343-353.

Michael-Titus AT, Albert M, Michael GJ, Michaelis T, Watanabe T, Frahm J, Pudovkina O, van der Hart MGC et al.(2008). SONU20176289, a compound combining partial dopamine D(2) receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression. Eur J Pharmacol vol. 598, (1-3) 43-50.

Hall JCE, Michael-Titus A, Perry VH, Priestley JV (2008). The inflammatory response and locomotor recovery following a spinal compression injury. JOURNAL OF NEUROIMMUNOLOGY. vol. 197, 172-172.

Malaspina A, Michael-Titus AT(2008). Is the modulation of retinoid and retinoid-associated signaling a future therapeutic strategy in neurological trauma and neurodegeneration?. J NEUROCHEM vol. 104, (3) 584-595.

Dyall SC, Michael-Titus AT(2008). Neurological Benefits of Omega-3 Fatty Acids. NEUROMOL MED vol. 10, (4) 219-235.

Jokic N, Ling YY, Ward RE, Michael-Titus AT, Priestley JV, Malaspina A(2007). Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis. J Neurochem vol. 103, (5) 1821-1833.

Huang WL, King VR, Curran OE, Dyall SC, Ward RE, Lal N, Priestley JV, Michael-Titus AT(2007). A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain vol. 130, (Pt 11) 3004-3019.

Michael-Titus AT(2007). Omega-3 fatty acids and neurological injury. Prostaglandins Leukot Essent Fatty Acids vol. 77, (5-6) 295-300.

King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT(2007). Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci vol. 26, (1) 90-100.

Makwana M, Dyall S, Raivich G, Michael-Titus A(2007). Effect of docosahexaenoic acid in a mouse facial nerve injury model. Oléagineux Corps gras Lipides vol. 14, (3-4) 233-233.

Dyall SC, Michael GJ, Michael-Titus AT(2007). Omega-3 polyunsaturated fatty acids reverse age-related decreases in retinoic acid receptors, retinoid x receptors and peroxisome-proliferator-activated receptors in rat forebrain. Oléagineux Corps gras Lipides vol. 14, (3-4) 232-232.

Dyall SC, Michael GJ, Whelpton R, Scott AG, Michael-Titus AT(2007). Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol Aging vol. 28, (3) 424-439.

Ward RE, Huang W, Hall JCE, Priestley JV, Michael-Titus AT(2007). Effect of docosahexaenoic acid on axonal damage after spinal cord injury. OCL - Oleagineux Corps Gras Lipides vol. 14, (3-4)

King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, Michael-Titus AT(2006). Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci vol. 26, (17) 4672-4680.

Penschuck S, Flagstad P, Didriksen M, Leist M, Michael-Titus AT(2006). Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. EUR J NEUROSCI vol. 23, (1) 279-284.

Flagstad P, Mørk A, Glenthøj BY, van Beek J, Michael-Titus AT, Didriksen M(2004). Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsychopharmacology vol. 29, (11) 2052-2064.

Nazir S, Michael GJ, Michael-Titus AT(2002). Distribution of NMDA and AMPA glutamate receptor subunits in rat prefrontal cortex and the effect of chronic imipramine treatment on the GluR2 subunit. BRIT J PHARMACOL vol. 135,

Hawkins A, McCune L, Whelpton R, Michael-Titus AT(2002). Effect of noradrenaline and 5-HT on excitatory amino acid release in rat prefrontal cortex. BRIT J PHARMACOL vol. 135,

Whelpton R, Michael-Titus AT, Fox A (2002). Bioanalysis of temoporfin, a new pharmacodynamic therapy agent. CHROMATOGRAPHIA. vol. 55, S177-S181.

Michael-Titus AT, Fernandes K, Setty H, Whelpton R(2002). In vivo metabolism and clearance of substance P and co-expressed tachykinins in rat striatum. Neuroscience vol. 110, (2) 277-286.

Toner CC, Connell K, Whelpton R, Bains S, Michael-Titus AT, McLaughlin DP, Stamford JA(2001). Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. BRIT J ANAESTH vol. 86, (4) 550-554.

Khan S, Whelpton R, Michael-Titus AT(2000). Substance P modulation of striatal dopamine outflow is determined by M<inf>1</inf> and M<inf>2</inf> muscarinic receptors in male Wistar rats. Neuroscience Letters vol. 293, (3) 179-182.

Michael-Titus AT, Bains S, Jeetle J, Whelpton R(2000). Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex--a possible mechanism of neuroprotection in major depression?. Neuroscience vol. 100, (4) 681-684.

Michael-Titus AT, Blackburn D, Connolly Y, Priestley JV, Whelpton R(1999). N- and C-terminal substance P fragments: differential effects on striatal [3H]substance P binding and NK1 receptor internalization. Neuroreport vol. 10, (10) 2209-2213.

Whelpton R, Michael-Titus AT, Stephens SM, Yau KW, Fengas D(1998). Identification of substance P metabolites using a combination of reversed-phase high-performance liquid chromatography and capillary electrophoresis. J Chromatogr B Biomed Sci Appl vol. 716, (1-2) 95-106.

Khan S, Sandhu J, Whelpton R, Michael-Titus AT(1998). Substance P fragments and striatal endogenous dopamine outflow: Interaction with substance P. Neuropeptides vol. 32, (6) 519-526.

MichaelTitus AT, Whelpton R, Stephens SM, Yau KW(1997). Metabolism of substance P in rat striatum studies using a combination of high performance liquid chromatography (HPLC) and capillary electrophoresis (CE). BRIT J PHARMACOL vol. 122, P79-P79.

Khan S, Sandhu J, Whelpton R, MichaelTitus AT(1996). Substance fragments, SP1-9 and SP6-11, modulate endogenous dopamine outflow in rat striatum. BRIT J PHARMACOL vol. 119, P175-P175.

Khan S, Whelpton R, Michael-Titus AT(1996). Evidence for modulatory effects of substance P fragments (1-4) and (8-11) on endogenous dopamine outflow in rat striatal slices. Neuroscience Letters vol. 205, (1) 33-36.

Khan S, Grogan E, Whelpton R, Michael-Titus AT(1996). N- and C-terminal substance P fragments modulate striatal dopamine outflow through a cholinergic link mediated by muscarinic receptors. Neuroscience vol. 73, (4) 919-927.

KHAN S, GROGAN E, WHELPTON R, MICHAELTITUS AT(1995). SUBSTANCE-P AND ITS FRAGMENT-(1-7) AND FRAGMENT-(5-11) MODULATE STRIATAL DOPAMINE OUTFLOW VIA A CHOLINERGIC LINK MEDIATED BY MUSCARINIC RECEPTORS. BRIT J PHARMACOL vol. 116, P96-P96.

Khan S, Brooks N, Whelpton R, Michael-Titus AT(1995). Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum. European Journal of Pharmacology vol. 282, (1-3) 229-233.

KHAN S, WHELPTON R, MICHAEL-TITUS A(1995). ENDOGENOUS DOPAMINE OUTFLOW FROM RAT STRIATAL SLICES IN STATIC AND DYNAMIC CONDITIONS. NEUROSCI RES COMMUN vol. 16, (3) 145-153.

IRAVANI MM, KHAN S, MICHAELTITUS A, WHELPTON R, KRUK ZL(1995). EFFECTS OF 6-HYDROXYDOPAMINE LESIONS IN THE VENTRAL TEGMENTAL AREA OR SUBSTANTIA-NIGRA ON DOPAMINE RELEASE IN SUBREGIONS OF THE RAT STRIATUM. BRIT J PHARMACOL vol. 114, P337-P337.

WHELPTON R, MICHAELTITUS AT, YAQUB Z(1995). TEMOPORFIN BINDING TO HUMAN SERUM-LIPOPROTEINS. BRIT J PHARMACOL vol. 114, P265-P265.

Das D, Rogers J, Michael-Titus AT(1994). Comparative study of the effects of mu, delta and kappa opioid agonists on 3H-dopamine uptake in rat striatum and nucleus accumbens. Neuropharmacology vol. 33, (2) 221-226.